Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand access soon.

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

Novo Nordisk’s weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly’s Zepbound, and now the ...

Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Here is a round-up of the lesser-known side effects from taking semaglutide and tirzepatide weight loss injectables such as ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...